Continuous subcutaneous glucose monitoring: The GlucoDay® system

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 6, 2002, Pages 429-433

  Maran, Alberto ^a   Poscia, A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Menarini Ricerche SpA   (Italy)

Author keywords

Blood glucose; Self monitoring

Indexed keywords

GLUCOSE;

ARTICLE; BLOOD GLUCOSE MONITORING; DEVICE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC REGULATION; MICRODIALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SELF MONITORING; SUBCUTANEOUS TISSUE; TISSUE LEVEL;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS; MICRODIALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0036966666     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
2. United Kingdom Prospective Diabetes Study Group 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group. Ann. Intern. Med. 128: 165-175, 1998.
3. Avignon A., Radauceanu A., Monnier L.: Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20: 1822-1826, 1997.
4. Muggeo M., Zoppini G., Bonora E., Brun E., Bonadonna R.C., Moghetti P., Verlato G.: Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 23: 45-50, 2000.
5. Bolinder J., Hagstrom-Toft E., Ungerstedt U., Amer P.: Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 20: 64-70, 1997.
6. Arner P, Bolinder J: Microdialysis of adipose tissue. J. Intern. Med. 230: 381-386, 1991.
7. Ash S.R., Rainier J.B., Zopp W.E., Truitt R.B., Janle E.M., Kissinger PT, Poulos JT: A subcutaneous capillary filtrate collector for measurement of blood chemistries. Asaio Journal 39: M699-705, 1993.
8. Aussedat B., Dupire-Angel M., Gifford R., Klein J.C., Wilson G.S., Reach G.: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am. J. Physiol. 278: E716-728, 2000.
9. Meyerhoff C., Bischof F., Sternberg F., Zier H., Pfeiffer E.F.: On Line Continuous Monitoring of Subcutaneous Tissue Glucose in Men by Combining Portable Glucosensor with Microdialysis. Diabetologia 35: 1087-1092, 1992.
10. Maran A., Crepaldi C., Tiengo A., Grassi G., Vitali E., Pagano G., Bistoni S., Calabrese G., Santeusanio F., Leonetti F., Ribaudo M., Di Mario U., Annuzzi G., Genovese S., Riccardi G., Previti M., Cucinotta D., Giorgino F., Bellomo A., Giorgino R., Poscia A., Varalli M.: Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 25: 347-352, 2002.